NCT01473498View on ClinicalTrials.gov

Personalized Mean Arterial Pressure Management on Renal Function During Septic Shock

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Septic ShockAcute Kidney Injury
Interventions
OTHER

Haemodynamic management

"Patients will be treated with fluid and norepinephrine to achieve and maintain a mean arterial pressure of 65 mm Hg. Then they will be randomized in two groups.~In the first group (study group, n=30), mean arterial pressure will be increased to 85 mm Hg for 72 hours by increasing the dose of norepinephrine in patients."

OTHER

Haemodynamic management

"Patients will be treated with fluid and norepinephrine to achieve and maintain a mean arterial pressure of 65 mm Hg. Then they will be randomized in two groups.~In this group (control group, n=30), mean arterial pressure will be maintained at 65 mm Hg."

Trial Locations (1)

94275

Reanimation Chirurgicale - Hôpital Kremlin Bicêtre, Le Kremlin-Bicêtre

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01473498 - Personalized Mean Arterial Pressure Management on Renal Function During Septic Shock | Biotech Hunter | Biotech Hunter